{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T10:32:00Z","timestamp":1768818720675,"version":"3.49.0"},"reference-count":68,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2020,5,10]],"date-time":"2020-05-10T00:00:00Z","timestamp":1589068800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["2 I01 RX000379-05"],"award-info":[{"award-number":["2 I01 RX000379-05"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxins"],"abstract":"<jats:p>Chronic osteoarthritis pain is an increasing worldwide problem. Treatment for osteoarthritis pain is generally inadequate or fraught with potential toxicities. Botulinum toxins (BoNTs) are potent inhibitors of neuropeptide release. Paralytic toxicity is due to inhibition at the neuromuscular junction, and this effect has been utilized for treatments of painful dystonias. Pain relief following BoNT muscle injection has been noted to be more significant than muscle weakness and hypothesized to occur because of the inhibition of peripheral neuropeptide release and reduction of peripheral sensitization. Because of this observation, BoNT has been studied as an intra-articular (IA) analgesic for chronic joint pain. In clinical trials, BoNT appears to be effective for nociceptive joint pain. No toxicity has been reported. In preclinical models of joint pain, BoNT is similarly effective. Examination of the dorsal root ganglion (DRG) and the central nervous system has shown that catalytically active BoNT is retrogradely transported by neurons and then transcytosed to afferent synapses in the brain. This suggests that pain relief may also be due to the central effects of the drug. In summary, BoNT appears to be safe and effective for the treatment of chronic joint pain. The long-term effects of IA BoNT are still being determined.<\/jats:p>","DOI":"10.3390\/toxins12050314","type":"journal-article","created":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T02:41:20Z","timestamp":1589251280000},"page":"314","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["The Use of Botulinum Toxin for the Treatment of Chronic Joint Pain: Clinical and Experimental Evidence"],"prefix":"10.3390","volume":"12","author":[{"given":"Nicole","family":"Blanshan","sequence":"first","affiliation":[{"name":"Minneapolis VA Health Care System, Minneapolis, MN 55455, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8285-5202","authenticated-orcid":false,"given":"Hollis","family":"Krug","sequence":"additional","affiliation":[{"name":"Minneapolis VA Health Care System, Minneapolis, MN 55455, USA"},{"name":"Department of Medicine, University of Minnesota, Minneapolis, MN 55455, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2020,5,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/art.21562","article-title":"Projections of US prevalence of arthritis and associated activity limitations","volume":"54","author":"Hootman","year":"2006","journal-title":"Arthritis Rheumatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1002\/art.39692","article-title":"Updated projected prevalence of self-reported doctor-diagnosed arthritis and arthritis-attributable activity limitation among US adults, 2015\u20132040","volume":"68","author":"Hootman","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/nrrheum.2013.138","article-title":"Towards a mechanism-based approach to pain management in osteoarthritis","volume":"9","author":"Malfait","year":"2013","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.joca.2013.03.018","article-title":"The epidemiology and impact of pain in osteoarthritis","volume":"21","author":"Neogi","year":"2013","journal-title":"Osteoarthr. Cartil."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.dhjo.2017.04.010","article-title":"Prevalence and causes of work disability among working-age US adults: 2011\u20132013","volume":"11","author":"Theis","year":"2018","journal-title":"Disabil. Health J."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1093\/ageing\/aft043","article-title":"New horizons in osteoarthritis","volume":"42","author":"Wenham","year":"2013","journal-title":"Age Ageing"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.joca.2010.01.013","article-title":"OARSI recommendations for the management of hip and knee osteoarthritis, Part III: Changes in evidence following systematic cumulative update of research published through January 2009","volume":"18","author":"Zhang","year":"2010","journal-title":"Osteoarthr. Cartil."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1001\/jama.2018.0899","article-title":"Effect of Opioid vs Nonopioid Medications on Pain-Related Function in Patients With Chronic Back Pain or Hip or Knee Osteoarthritis Pain: The SPACE Randomized Clinical TrialOpioid vs Nonopioid Medications on Pain-Related FunctionOpioid vs Nonopioid Medications on Pain-Related Function","volume":"319","author":"Krebs","year":"2018","journal-title":"JAMA"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.15585\/mmwr.mm675152e1","article-title":"Drug and Opioid-Involved Overdose Deaths - United States, 2013\u20132017","volume":"67","author":"Scholl","year":"2018","journal-title":"MMWR. Morb. Mortal. Wkly. Rep."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/jgs.12148","article-title":"Greater number of narcotic analgesic prescriptions for osteoarthritis is associated with falls and fractures in elderly adults","volume":"61","author":"Rolita","year":"2013","journal-title":"J. Am. Geriatr. Soc."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1056\/NEJMoa0708333","article-title":"A randomized trial of arthroscopic surgery for osteoarthritis of the knee","volume":"359","author":"Kirkley","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1056\/NEJMoa013259","article-title":"A controlled trial of arthroscopic surgery for osteoarthritis of the knee","volume":"347","author":"Mosely","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.2106\/00004623-201310160-00010","article-title":"The American Academy of orthopaedic surgeons evidence-based guideline on: Treatment of Osteoarthritis of the Knee","volume":"95","author":"Jevsevar","year":"2013","journal-title":"J. Bone Joint Surg. Am."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/nrd4612","article-title":"Drug developers reboot anti-NGF pain programmes","volume":"14","author":"Mullard","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1002\/art.40894","article-title":"Randomized, Double-Blind, Placebo-Controlled Trial of Intraarticular Trans-Capsaicin for Pain Associated with Osteoarthritis of the Knee","volume":"71","author":"Stevens","year":"2019","journal-title":"Arthritis Rheumatol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1080\/03009742.2016.1203988","article-title":"Intra-articular onabotulinumtoxinA in osteoarthritis knee pain: Effect on human mechanistic pain biomarkers and clinical pain","volume":"46","author":"Jiang","year":"2017","journal-title":"Scand. J. Rheumatol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.mpaic.2016.06.010","article-title":"The neurobiology of chronic pain states","volume":"17","author":"Dickenson","year":"2016","journal-title":"Anaesth. Intensive Care Med."},{"key":"ref_18","unstructured":"Firestein, G.S., Budd, R.C., Harris, E.D., McInnes, I.B., Ruddy, S., and Sergent, J.S. (2009). Chronic Musculoskeletal Pain. Kelly\u2019s Textbook of Rheumatology, Saunders Elsevier. [8th ed.]."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/infdis\/jit449","article-title":"A novel strain of Clostridium botulinum that produces type B and type H botulinum toxins","volume":"209","author":"Barash","year":"2014","journal-title":"J. Infect. Dis."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.coph.2004.12.006","article-title":"Botulinal neurotoxins: Revival of an old killer","volume":"5","author":"Montecucco","year":"2005","journal-title":"Curr. Opin. Pharmacol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.pneurobio.2014.06.001","article-title":"Botulinum toxin A, brain and pain","volume":"119\u2013120","author":"Matak","year":"2014","journal-title":"Prog. Neurobiol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.3390\/toxins7083127","article-title":"Botulinum Toxin for Neuropathic Pain: A Review of the Literature","volume":"7","author":"Oh","year":"2015","journal-title":"Toxins"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"16993","DOI":"10.1074\/jbc.M710442200","article-title":"Novel chimeras of botulinum neurotoxins A and E unveil contributions from the binding, translocation, and protease domains to their functional characteristics","volume":"283","author":"Wang","year":"2008","journal-title":"J. Biol. Chem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/BF03033937","article-title":"Long term effects of intra-articular botulinum toxin A for refractory joint pain","volume":"9","author":"Mahowald","year":"2006","journal-title":"Neurotox. Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0041-0101(99)00153-1","article-title":"Sensitivity of embryonic rat dorsal root ganglia neurons to Clostridium botulinum neurotoxins","volume":"38","author":"Welch","year":"2000","journal-title":"Toxicon"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1526-4610.2004.04007.x","article-title":"Regulation of calcitonin gene-related peptide secretion from trigeminal nerve cells by botulinum toxin type A: Implications for migraine therapy","volume":"44","author":"Durham","year":"2004","journal-title":"Headache"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1242\/jcs.012211","article-title":"Synaptobrevin I mediates exocytosis of CGRP from sensory neurons and inhibition by botulinum toxins reflects their anti-nociceptive potential","volume":"120","author":"Meng","year":"2007","journal-title":"J. Cell Sci."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"3935","DOI":"10.1113\/jphysiol.2013.255075","article-title":"SNARE proteins are essential in the potentiation of NMDA receptors by group II metabotropic glutamate receptors","volume":"591","author":"Cheng","year":"2013","journal-title":"J. Physiol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"25665","DOI":"10.1074\/jbc.M311515200","article-title":"Regulated exocytosis contributes to protein kinase C potentiation of vanilloid receptor activity","volume":"279","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jbspin.2015.10.001","article-title":"Usefulness of intra-articular botulinum toxin injections. A systematic review","volume":"83","author":"Kheniouia","year":"2016","journal-title":"Jt. Bone Spine"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3899\/jrheum.101081","article-title":"Botulinum toxin for shoulder pain: A cochrane systematic review","volume":"38","author":"Singh","year":"2011","journal-title":"J. Rheumatol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1016\/j.apmr.2015.06.018","article-title":"Effectiveness of Botulinum Toxin for Shoulder Pain Treatment: A Systematic Review and Meta-Analysis","volume":"96","author":"Wu","year":"2015","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1177\/0269215516644951","article-title":"Intra-articular injections of botulinum toxin a for refractory joint pain: A systematic review and meta-analysis","volume":"31","author":"Wu","year":"2017","journal-title":"Clin. Rehabil."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/AJP.0000000000000538","article-title":"Efficacy of Intra-Articular Botulinum Toxin in Osteoarticular Joint Pain: A Meta-Analysis of Randomized Controlled Trials","volume":"34","author":"Courseau","year":"2018","journal-title":"Clin. J. Pain"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1757-1146-7-9","article-title":"Efficacy of intraarticular botulinum toxin A and intraarticular hyaluronate plus rehabilitation exercise in patients with unilateral ankle osteoarthritis: A randomized controlled trial","volume":"7","author":"Sun","year":"2014","journal-title":"J. Foot Ankle Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"256","DOI":"10.5435\/JAAOS-22-04-256","article-title":"Non-arthroplasty treatment of osteoarthritis of the knee","volume":"22","author":"Sanders","year":"2014","journal-title":"J. Am. Acad. Orthop. Surg."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Eleopra, R., Rinaldo, S., Lettieri, C., Santamato, A., Bortolotti, P., Lentino, C., Tamborino, C., Causero, A., and Devigili, G. (2018). AbobotulinumtoxinA: A New Therapy for Hip Osteoarthritis. A Prospective Randomized Double-Blind Multicenter Study. Toxins, 10.","DOI":"10.3390\/toxins10110448"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.semarthrit.2016.04.003","article-title":"Clinical benefit of intra-articular saline as a comparator in clinical trials of knee osteoarthritis treatments: A systematic review and meta-analysis of randomized trials","volume":"46","author":"Altman","year":"2016","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1136\/ard.2008.092015","article-title":"The placebo effect and its determinants in osteoarthritis: Meta-analysis of randomised controlled trials","volume":"67","author":"Zhang","year":"2008","journal-title":"Ann. Rheum. Dis."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.toxicon.2019.04.003","article-title":"Intra-articular botulinum toxin type A for treatment of knee osteoarthritis: Clinical trial","volume":"165","author":"Najafi","year":"2019","journal-title":"Toxicon"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1177\/0269215519827996","article-title":"Comparison between intra-articular Botulinum toxin type A, corticosteroid, and saline in knee osteoarthritis: A randomized controlled trial","volume":"33","author":"Mendes","year":"2019","journal-title":"Clin. Rehabil."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.joca.2018.05.001","article-title":"Efficacy and safety of single-dose onabotulinumtoxinA in the treatment of symptoms of osteoarthritis of the knee: Results of a placebo-controlled, double-blind study","volume":"26","author":"McAlindon","year":"2018","journal-title":"Osteoarthr. Cartil."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"534","DOI":"10.2340\/16501977-2340","article-title":"Effect of therapeutic exercise on knee osteoarthritis after intra-articular injection of botulinum toxin type A, hyaluronate or saline: A randomized controlled trial","volume":"50","author":"Bao","year":"2018","journal-title":"J. Rehabil. Med."},{"key":"ref_44","first-page":"1127","article-title":"Effects of Botulinum Toxin Landmark-Guided Intra-articular Injection in Subjects with Knee Osteoarthritis","volume":"8","author":"Hsieh","year":"2016","journal-title":"PM R J. Inj. Funct. Rehabil."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"208","DOI":"10.5535\/arm.2013.37.2.208","article-title":"A comparison of the short-term effects of a botulinum toxin type a and triamcinolone acetate injection on adhesive capsulitis of the shoulder","volume":"37","author":"Joo","year":"2013","journal-title":"Ann. Rehabil. Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.3899\/jrheum.100336","article-title":"Intra-articular Botulinum Toxin A for Refractory Painful Total Knee Arthroplasty: A Randomized, Controlled Trial","volume":"37","author":"Singh","year":"2010","journal-title":"J. Rheumatol."},{"key":"ref_47","first-page":"268","article-title":"Efficacy of intra-articular botulinum toxin type A in painful knee osteoarthritis: A pilot study","volume":"2","author":"Boon","year":"2010","journal-title":"PM R J. Inj. Funct. Rehabil."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S1726-4901(10)70126-X","article-title":"Therapeutic effects of intra-articular botulinum neurotoxin in advanced knee osteoarthritis","volume":"73","author":"Chou","year":"2010","journal-title":"J. Chin. Med. Assoc."},{"key":"ref_49","first-page":"205","article-title":"IA botulinum toxin A for refractory shoulder pain: A randomized, double-blinded, placebo-controlled trial","volume":"153","author":"Singh","year":"2009","journal-title":"Trans. Res. J. Lab. Clin. Med."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1111\/j.1526-4637.2009.00711.x","article-title":"Pain behavior measures to quantitate joint pain and response to neurotoxin treatment in murine models of arthritis","volume":"10","author":"Krug","year":"2009","journal-title":"Pain Med."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.toxicon.2018.11.307","article-title":"The analgesic effect of intraarticular OnabotulinumtoxinA in a female murine model of collagenase induced chronic degenerative monoarthritis","volume":"158","author":"Blanshan","year":"2019","journal-title":"Toxicon"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2147\/JPR.S12520","article-title":"Analgesic effects of intra-articular botulinum toxin Type B in a murine model of chronic degenerative knee arthritis pain","volume":"3","author":"Anderson","year":"2010","journal-title":"J. Pain. Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.toxicon.2017.05.001","article-title":"Botulinum toxin type A reduces TRPV1 expression in the dorsal root ganglion in rats with adjuvant-arthritis pain","volume":"133","author":"Fan","year":"2017","journal-title":"Toxicon"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.toxicon.2017.02.010","article-title":"Botulinum toxin type A reduces inflammatory hypernociception induced by arthritis in the temporomadibular joint of rats","volume":"129","author":"Lora","year":"2017","journal-title":"Toxicon"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Heikkila, H.M., Hielm-Bjorkman, A.K., Innes, J.F., and Laitinen-Vapaavuori, O.M. (2017). The effect of intra-articular botulinum toxin A on substance P, prostaglandin E2, and tumor necrosis factor alpha in the canine osteoarthritic joint. BMC Vet. Res., 13.","DOI":"10.1186\/s12917-017-0990-y"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1292\/jvms.18-0506","article-title":"Intra-articular botulinum toxin A (BoNT\/A) for pain management in dogs with osteoarthritis secondary to hip dysplasia: A randomized controlled clinical trial","volume":"81","author":"Nicacio","year":"2019","journal-title":"J. Vet. Med. Sci."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.tvjl.2014.01.020","article-title":"Intra-articular botulinum toxin A for the treatment of osteoarthritic joint pain in dogs: A randomized, double-blinded, placebo-controlled clinical trial","volume":"200","author":"Heikkila","year":"2014","journal-title":"Vet. J."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Heikkila, H.M., Jokinen, T.S., Syrja, P., Junnila, J., Hielm-Bjorkman, A., and Laitinen-Vapaavuori, O. (2018). Assessing adverse effects of intra-articular botulinum toxin A in healthy Beagle dogs: A placebo-controlled, blinded, randomized trial. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0191043"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1097\/j.pain.0000000000000478","article-title":"Nonparalytic botulinum molecules for the control of pain","volume":"157","author":"Mangione","year":"2016","journal-title":"Pain"},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Weise, D., Weise, C.M., and Naumann, M. (2019). Central Effects of Botulinum Neurotoxin-Evidence from Human Studies. Toxins, 11.","DOI":"10.3390\/toxins11010021"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/PHM.0b013e318168d36c","article-title":"Influence of Botulinum Toxin Type A Treatment of Elbow Flexor Spasticity on Hemiparetic Gait","volume":"87","author":"Esquenazi","year":"2008","journal-title":"Am. J. Phys. Med. Rehabil."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1113\/jphysiol.2012.239178","article-title":"Beyond muscular effects: Depression of spinal recurrent inhibition after botulinum neurotoxin A","volume":"591","author":"Aymard","year":"2013","journal-title":"J. Physiol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1113\/jphysiol.2012.242131","article-title":"Transsynaptic inhibition of spinal transmission by A2 botulinum toxin","volume":"591","author":"Akaike","year":"2013","journal-title":"J. Physiol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.pain.2013.12.009","article-title":"Botulinum toxin B in the sensory afferent: Transmitter release, spinal activation, and pain behavior","volume":"155","author":"Marino","year":"2014","journal-title":"Pain"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1002\/ejp.1146","article-title":"Role of central versus peripheral opioid system in antinociceptive and anti-inflammatory effect of botulinum toxin type A in trigeminal region","volume":"22","author":"Filipovic","year":"2018","journal-title":"Eur. J. Pain"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"3689","DOI":"10.1523\/JNEUROSCI.0375-08.2008","article-title":"Long-distance retrograde effects of botulinum neurotoxin A","volume":"28","author":"Antonucci","year":"2008","journal-title":"J. Neurosci."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/ejp.995","article-title":"Bilateral analgesic effects of abobotulinumtoxinA (Dysport((R))) following unilateral administration in the rat","volume":"21","author":"Chabrier","year":"2017","journal-title":"Eur. J. Pain"},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Marinelli, S., Vacca, V., Ricordy, R., Uggenti, C., Tata, A.M., Luvisetto, S., and Pavone, F. (2012). The analgesic effect on neuropathic pain of retrogradely transported botulinum neurotoxin A involves Schwann cells and astrocytes. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0047977"}],"container-title":["Toxins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6651\/12\/5\/314\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:27:27Z","timestamp":1760174847000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6651\/12\/5\/314"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,10]]},"references-count":68,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2020,5]]}},"alternative-id":["toxins12050314"],"URL":"https:\/\/doi.org\/10.3390\/toxins12050314","relation":{},"ISSN":["2072-6651"],"issn-type":[{"value":"2072-6651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,10]]}}}